๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chengdu
Clinical trial register · China

Clinical Trials in Chengdu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Chengdu 7 Beijing 1 Xuzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Chengdu7 Beijing1 Xuzhou1
All 3 locations
Target enrolment
to

Trials with a site in Chengdu

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
NCT07763301Liver Cancer, Pancreatic Cancer, Biliary Tract Cancer (BTC)
West China Hospital
Phase 1
9
Chengdu
2026-08-01
Recruiting
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
NCT07295275Liver Cancer
West China Hospital
Observational
200
Beijing, Xuzhou, Chengdu
2026-03-01
Recruiting
Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection
NCT07295340Liver Cancer
West China Hospital
Observational
20
Chengdu
2026-01-01
Recruiting
PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.
NCT07053072Liver Cancer
West China Hospital
Phase 1
9
Chengdu
2025-10-23
Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814Sarcomatoid Carcinoma, Liver Cancer, Adjuvant Therapy
West China Hospital
Observational
50
Chengdu
2025-04-05
Recruiting
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
NCT06341270Liver Cancer
West China Hospital
Not applicable
524
Chengdu
2024-05-06
Recruiting
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy
NCT06406244Liver Cancer
West China Hospital
Not applicable
524
Chengdu
2024-04-20
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/chengdu

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Chengdu that also match the filters currently applied.

How many clinical trials are recruiting in Chengdu?

7 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chengdu), 7 studies
PhaseStudiesRecruitingShare
Observational3342.9%
Not applicable2228.6%
Phase 12228.6%

Most active sponsors

Lead sponsors with the most studies (Chengdu)
Lead sponsorStudiesRecruiting
West China Hospital77
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.